乳头脏细胞癌:对未来临床试验的回顾
Benjamin L Maughan1, Deepika Sirohi2,3
1Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA. Benjamin.maughan@hci.utah.edu.
Current treatment options in oncology
|July 5, 2023
概括
乳头脏细胞癌 (PRCC) 的最新分类强调分子亚型. 目前对以前未经治疗的PRCC的治疗是cabozantinib,免疫检查点抑制剂在正在进行的试验中显示出有前途.
科学领域:
- 在瘤学瘤学.
- 细胞癌研究 细胞癌研究
- 分子病理学分子病理学
背景情况:
- 乳头性细胞癌 (PRCC) 是细胞癌的一个独特的亚型,具有独特的分子驱动因素.
- 世界卫生组织 (WHO) 2022年分类优先考虑PRCC的分子生物学,远离较旧的形态分类.
- 目前的研究强调了在PRCC临床试验中需要分子定义的患者队列.
研究的目的:
- 讨论基于分子特征的PRCC不断变化的分类.
- 对以前未经治疗的PRCC的当前护理标准进行审查.
- 强调PRCC正在进行和未来临床试验的重要性,特别是那些验证免疫检查点抑制剂疗法的临床试验.
主要方法:
- 对PRCC治疗的最近临床试验数据 (S1500,PAPMET) 的审查.
- 分析单臂试验的研究结果,研究PRCC中的免疫检查点抑制剂.
- 讨论PRCC从形态到分子分类系统的过渡.
主要成果:
- 卡博赞提尼布是基于疾病特异性临床试验而建立的治疗先验PRCC的护理标准.
- 免疫检查点抑制剂疗法在PRCC中表现出显著的活性,这是前性临床试验所证明的.
- 单臂试验表明组合免疫疗法有希望的结果,但需要通过随机研究进行验证.
结论:
- 世卫组织2022年分类对PRCC分子亚型的关注是一个关键的进步.
- 未来的临床试验应该通过分子诊断对患者进行分层,以提高科学有效性.
- 随机试验对于确认PRCC中免疫检查点抑制剂的疗效和完善护理标准至关重要.
相关概念视频
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K